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ABSTRACT
Objective The purpose of this study was to examine the 
risk of diabetes associated with the presence or absence 
of chronic low back pain, considering both cross-sectional 
and cohort data.
Research design and methods Analyses were based 
on the Norwegian HUNT2 and HUNT3 surveys of Nord-
Trøndelag County. The prevalence of diabetes was 
compared in groups with and without chronic low back 
pain among 45 157 participants aged 30–69 years. 
Associations between low back pain at baseline and risk 
of diabetes were examined in an 11-year follow-up of 30 
380 individuals with no baseline diagnosis of diabetes. 
The comorbidity between diabetes and low back pain was 
assessed at the end of follow-up. All analyses were carried 
out considering generalized linear models incorporating 
adjustment for other relevant risk factors.
Results Cross-sectional analyses did not reveal any 
association between low back pain and diabetes. With 
adjustment for age, body mass index, physical activity and 
smoking, the cohort study of women showed a signi"cant 
association between low back pain at baseline and risk 
of diabetes (RR 1.30; 95%  CI 1.09 to 1.54, p=0.003). The 
association differed between age groups (p=0.015), with 
a stronger association in relatively young women. In men, 
no association was found in the whole age range (RR 
1.02; 95%  CI 0.86 to 1.21, p=0.82). No association was 
observed between diabetes and chronic low back pain at 
the end of follow-up.
Conclusion Among younger women, those with chronic 
low back pain may have an increased risk of diabetes.
INTRODUCTION
Diabetes is one of the most important meta-
bolic disorders today.1 Low back pain is the 
most common musculoskeletal disorder and 
the leading cause of disability globally.2 Low 
back pain is frequently seen among patients 
with diabetes,3 but it is not known whether 
this reflects a causal relationship.4 There 
are indications that diabetes is associated 
with disc degeneration,5 6 and diabetes may 
also predispose to lumbar spinal stenosis.7 
Diabetes and low back pain share important 
risk factors as overweight and obesity,8 9 phys-
ical inactivity10 11 and smoking.12 13 It is uncer-
tain, however, whether associations between 
back pain and diabetes will be maintained in 
studies designed to assess etiological relation-
ships, adjusting for established risk factors.
In epidemiological studies, the prevalence 
of musculoskeletal pain has been found to 
be increased in patients with type 2 diabetes 
in regions such as the shoulder, neck, back, 
arms, knees and hips.14 There are very few 
population-based studies of relations between 
diabetes and back pain. A large cross-sec-
tional study found an association between 
prevalence of chronic low back pain and 
diabetes.15 A higher risk of back, neck and/or 
shoulder pain was found among individuals 
with diabetes in a large 4-year prospective 
study.16 In a 2–4 year follow-up study of twins, 
back pain was not found to increase the risk 
of diabetes significantly.4
The purpose of the present study was to 
explore associations between chronic low 
back pain and risk of diabetes in a Norwe-
gian population, taking into account estab-
lished risk factors. Specifically, we address 
the following questions. Does the preva-
lence of diabetes differ between groups 
with and without chronic low back pain in a 
Significance of this study
What is already known about this subject?
 Low back pain is commonly seen among patients 
with diabetes, but it is not known whether this re-
&ects a causal relationship.
What are the new "ndings?
 Women without diabetes who experience chronic 
low back pain have an increased risk of being di-
agnosed with diabetes in the subsequent 11-year 
interval.
How might these results change the focus of 
research or clinical practice?
 More attention should be paid to associations be-
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cross-sectional setting? In an 11-year follow-up, does the 
risk of diabetes depend on having chronic low back pain 
at start of follow-up? Among individuals with neither 
diabetes nor chronic low back pain at start of follow-up, 
do diabetes and chronic low back pain show any associa-
tion in comorbidity at the end of follow-up?
RESEARCH DESIGN AND METHODS
Study design
Three health surveys have been carried out in the county 
of Nord-Trøndelag in Norway,17 HUNT1 in 1984–1986, 
HUNT2 in 1995–1997 and HUNT3 in 2006–2008. The 
present work is based on data from the second survey, 
HUNT2,18 combined with follow-up data from the third 
survey, HUNT3.17 The whole population in Nord-Trøn-
delag aged 20 years and above were invited to participate 
in the HUNT2 survey. Each person was asked to fill in 
a questionnaire on health status. Everybody was invited 
to a clinical examination, which included measurements 
of height and weight and drawing non-fasting blood 
samples. After 11 years, similar information from a ques-
tionnaire and a clinical examination was collected in the 
HUNT3 survey.
A question in the HUNT2 questionnaire was: ‘Do 
you have or have you had diabetes?’ and participants 
answering yes were then asked to report ‘age at first time’. 
In HUNT3, similar questions about diabetes were asked. 
In a validation study, self-reported diabetes in HUNT1 
was compared with general practitioners’ records, and 
the self-report had excellent positive (96.4%) and nega-
tive (99.7%) predictive values.19
Another question in HUNT2 and HUNT3 was 
expressed in this manner: ‘During the last year, have 
you suffered from pain and/or stiffness in your muscles 
and joints that has lasted for at least three consecutive 
months?’ Any participant who answered yes was then 
given the following question: ‘Where did you have these 
complaints?’ The questionnaires listed several body 
regions. Individuals answering yes to the first question 
and specifying the lower back as a relevant region were 
classified as having chronic low back pain.20 The ques-
tionnaires also elicited information on physical activity in 
leisure time, smoking and education.
Each participant in the HUNT2 and HUNT3 surveys 
signed a written informed consent regarding the collec-
tion and use of data for research purposes.
Design of the cross-sectional study
Among individuals with information available about 
diabetes and chronic low back pain, associations between 
chronic low back pain and diabetes were explored in the 
cross-sectional HUNT2 survey. Because of low participa-
tion rates in the youngest and oldest age groups,21 the 
study was restricted to those aged 30–69 years when they 
participated in HUNT2. Information about residence 
status was supplied by national registries and linked by 
use of the unique Norwegian personal identification 
numbers.
At the time of the HUNT2 survey, the total popula-
tion consisted of 58 928 persons in the age interval of 
30–69 years. The cross-sectional study included 45 157 
participants, 23 578 women and 21 579 men, with known 
information about diabetes and chronic low back pain in 
HUNT2, corresponding to a response rate of 76.6%.
Design of the cohort study
An 11-year prospective study was conducted considering 
baseline data from HUNT2 combined with follow-up data 
from HUNT3. The study aimed at the cohort consisting 
of 44 183 individuals without diabetes, aged 30–69 years 
when they participated in the HUNT2 survey. During the 
period of follow-up, 2542 members of this cohort died 
and 1542 individuals left the county of Nord-Trøndelag. 
Furthermore, 9719 members of the cohort residing in 
Nord-Trøndelag at the time of HUNT3 did not partici-
pate or did not supply information about diabetes. Thus, 
a total of 30 380 individuals, 16 552 women and 13 828 
men, were available for analysis after follow-up, repre-
senting 75.8% of the remaining individuals resident in 
the county and 68.8% of the original cohort.
The cohort study of comorbidity included 10 131 
women and 8561 men without diabetes or chronic low 
back pain at baseline and with known status of low back 
pain and diabetes at the end of follow-up.
Covariate assessment
Baseline age was categorized into 10-year intervals in the 
main statistical analyses. Body mass index (BMI), defined 
as weight/height2 and computed in kg/m2, was subdi-
vided into four groups: ≤24.9, 25–29.9, 30–34.9 and ≥35. 
For physical activity in leisure time, including going to 
work, the first category comprised those engaged in light 
activity only or hard physical activity (leading to sweating 
or being out of breath) <1 hour per week. Other catego-
ries represented hard physical activity 1–2 and ≥3 hours 
per week. In a reliability and validity study,22 the question 
on hard activity in leisure time showed acceptable repeat-
ability and represented a reasonably valid measure of 
vigorous activities. Categories of cigarette smoking repre-
sented current daily smoking, previous daily smoking 
and never daily smoking.
Particular analyses also included duration of education 
as a covariate, with three groups, ≤9, 10–12 and ≥13 years. 
Serum total cholesterol, high-density lipoprotein (HDL) 
cholesterol and triglyceride levels, measured by enzy-
matic colorimetric methods, were included as contin-
uous covariates. Triglyceride levels were logarithmically 
transformed.
Statistical analysis
Associations between low back pain and prevalence or risk 
of diabetes were evaluated by generalized linear modeling 
for binomial data with a log link, with adjustment for 
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Table 1 Number of individuals included in the cross-
sectional study, the cohort study of diabetes risk and the 










  LBP 
   Absent 16 768 296 (1.8) 16 482 397 (2.4)
   Present 6810 148 (2.2) 5097 133 (2.6)
Cohort study of diabetes risk† 
  LBP at baseline 
   Absent 11 883 364 (3.1) 10 511 453 (4.3)
   Present 4669 222 (4.8) 3317 163 (4.9)
  Age at baseline (years) 
   30–39 4315 55 (1.3) 3321 57 (1.7)
   40–49 5314 152 (2.9) 4584 172 (3.8)
   50–59 4281 205 (4.8) 3698 240 (6.5)
   60–69 2642 174 (6.6) 2225 147 (6.6)
  BMI at baseline (kg/m2) 
   ≤24.9 7555 66 (0.9) 4470 50 (1.1)
   25–29.9 6367 215 (3.4) 7478 297 (4.0)
   30–34.9 1994 198 (9.9) 1634 197 (12.1)
   ≥35 594 105 (17.7) 211 67 (31.8)
Cohort study of comorbidity‡ 
  LBP at follow-up 
   Absent 8049 252 (3.1) 7317 316 (4.3)
   Present 2082 60 (2.9) 1244 59 (4.7)
*Includes individuals with information at baseline, with possible 
diagnosis of diabetes at the same stage.
†Includes individuals without diabetes at baseline, under risk of 
diabetes at the end of follow-up.
‡Includes individuals without diabetes or LBP at baseline, under 
risk of diabetes and LBP at the end of follow-up.
BMI, body mass index; LBP, low back pain.
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overall risk and in associations with low back pain23 and 
diabetes,24 all analyses were carried out separately for 
women and men. The first analyses included adjustment 
for age only, and additional adjustment was then intro-
duced for other factors known to influence the risk of 
both diabetes and low back pain, as BMI,8 9 25 physical 
activity in leisure time10 11 and smoking.12 13 In the main 
analyses, all variables adjusted for were regarded as cate-
gorical. Separate tests were performed for interaction 
between low back pain and each adjustment variable. 
Because of missing values, somewhat fewer individuals 
were included in the analyses with complete adjustment. 
The total number of individuals included in each analysis 
is shown in the tables.
In particular sensitivity analyses in the cohort study of 
risk of diabetes, additional adjustment was introduced 
for duration of education, total cholesterol, HDL choles-
terol or triglycerides.
Comorbidity was assessed by including low back pain 
status at the end of follow-up as a covariate in the analysis 
of risk of diabetes.
All statistical analyses were carried out using IBM SPSS 
V.25 (IBM Corp, Armonk, New York, USA).
RESULTS
Descriptive results
In the cross-sectional study, a total of 444 women (1.9%) 
and 530 men (2.5%) reported that they had diabetes 
(table 1). The percentage of diabetes was only slightly 
greater among male participants with low back pain than 
among those without such pain (table 1). The difference 
was more pronounced among females.
In the cohort study, a total of 586 women (3.5%) 
and 616 men (4.5%) reported diabetes at the end of 
follow-up. This study showed somewhat larger percent-
ages of diabetes at the end of follow-up in the groups with 
low back pain present than in the groups with pain absent 
at baseline (table 1). In the cohort study of diabetes risk, 
the percentages of participants reporting diabetes at the 
end of follow-up depended markedly on both age and 
BMI at baseline.
In the cohort study of comorbidity, percentages of 
diabetes cross-tabulated with low back pain at the end of 
follow-up among those without either condition at base-
line did not show a consistent picture (table 1).
Analytic results in the cross-sectional study
In statistical analyses based on generalized linear models, 
no association was found between low back pain and prev-
alence of diabetes in the cross-sectional study (table 2), 
neither with adjustment for age nor with complete adjust-
ment. In particular, no interaction was observed with 
linear age (p=0.20 for women and p=0.21 for men) or 
with sex (p=0.64).
Analytic results in the cohort study
In the cohort study of women, a statistically significant 
association was found between low back pain at baseline 
and risk of diabetes (table 3). After complete adjustment, 
women with chronic low back pain experienced about 
30% increased risk of diabetes at the end of follow-up. In 
separate sensitivity analyses excluding all individuals with 
a diagnosis of diabetes known to have occurred during 
the first 2 or 4 years of follow-up, slightly stronger rela-
tionships were observed (results not shown). No associa-
tion between low back pain and diabetes was indicated in 
men (table 3), but the sex difference was not statistically 
significant (p=0.11).
Separate adjusted analyses with the original BMI values 
included as a continuous variable with polynomial effect 
produced quite similar results to those shown in table 3. 
Modeling the age effect by a polynomial also led to 
almost the same results. Further adjustment for duration 
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Table 2 Associations between low back pain and 
prevalence of diabetes in the cross-sectional study
Women Men
Adjustment for age 




  P values 0.27 0.61
  Number of individuals included 23 578 21 579
Complete adjustment* 




  P values 0.70 0.63
  Number of individuals included 21 292 20 094
*Adjustment for age, BMI, physical activity and smoking.
BMI, body mass index; LBP, low back pain; PR, prevalence ratio.
Table 3 Associations between baseline low back pain and 
risk of diabetes at the end of follow-up in the cohort study 
of individuals without diabetes at baseline
Women Men
Adjustment for age 




  P values <0.001 0.68
  Number of individuals included 16 552 13 828
Adjustment for age and BMI 




  P values 0.005 0.86
  Number of individuals included 16 510 13 793
Complete adjustment* 




  P values 0.003 0.82
  Number of individuals included 15 349 13 141
*Adjustment for baseline age, BMI, physical activity and smoking.
BMI, body mass index; LBP, low back pain.
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cholesterol or triglycerides did not materially affect risk 
estimates for baseline low back pain (results not shown).
Considering the risk of diabetes in women, an inter-
action between age and low back pain at baseline was 
observed (table 4). The strongest association between low 
back pain and risk of diabetes was found among women 
in the lowest age interval 30–39 years. In this group, 
women with low back pain showed an estimated increase 
in risk of about 80%. With increasing age, the association 
in women became weaker, and by the age of 60–69 years, 
no association remained. No statistically significant inter-
actions were found with other risk factors.
No association between diabetes and chronic low back 
pain regarded as comorbid conditions at the end of 
follow-up could be established in either sex (table 5), and 
no age interaction was found.
DISCUSSION
In this cohort, an overall relationship was found in 
women between chronic low back pain at baseline and 
risk of diabetes after 11 years. The relationship was 
considerably stronger in women younger than 40 years. 
In men, no association was observed. No excess comor-
bidity between diabetes and chronic low back pain was 
found in the cohort study. The cross-sectional study did 
not reveal any association.
Our analysis is based on a large population-based data 
set, with the overwhelming majority of the participants 
belonging to a homogeneous ethnic group. Less than 3% 
of the population had a non-Caucasian background.18 
The area is representative of Norway, but includes no 
major cities. The general income is slightly below the 
average in Norway.18 In the period considered here, the 
health system in Norway was substantially uniform, based 
on public services. Available information about potential 
confounders as BMI, physical activity and smoking made 
it possible to carry out essential adjustments. Former 
work using data from the HUNT population has shown 
that BMI is strongly associated with both diabetes26 and 
low back pain.9 BMI was categorized into four major 
groups representing normal weight or underweight, 
overweight, obesity and severe obesity. This might leave 
residual confounding by BMI, but separate analyses with 
BMI as a continuous variable indicated that this problem 
was very minor. Unfortunately, relatively large parts of the 
population did not participate in the surveys.
Taking into account the results of the validity study,19 
the information supplied by the participants about 
diabetes most likely reflects nearly the true situation 
considering the previous diagnoses. It is well known, 
however, that a substantial proportion of those with 
diabetes have not received a formal diagnosis,27 although 
this must apply both to participants with and without low 
back pain. Those suffering from chronic low back pain 
may still have sought medical attention more frequently 
than the general population. If this involved drawing 
blood samples, diabetes may have been detected more 
easily, generating a false association between low back 
pain and risk of diabetes. Another possible source of 
error is reverse causation if undetected diabetes or predi-
abetes affects the likelihood of experiencing low back 
pain. Short-term effects of this kind may to some extent 
be checked by excluding the first part of the follow-up 
period from the analysis. In this study, exclusion of cases 
of diabetes reported to occur in the first 2 or 4 years 
of follow-up did not weaken the association observed 
among women. The total follow-up period was in any case 
considerably longer than in comparable studies.4 16
The diagnosis of low back pain was self-reported, but 
only serious cases lasting for at least 3 months were 
supposed to be included. Pain intensity was not recorded 
and pain status in the 11-year period between the HUNT2 
and HUNT3 surveys is unknown.
In a Danish study of patients with type 2 diabetes 
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Table 4 Associations between low back pain and risk of diabetes by baseline age, in the cohort study of individuals without 
diabetes at baseline
Women Men
No adjustment Complete adjustment* No adjustment Complete adjustment*
RR† (95% CI) RR† (95% CI) RR† (95% CI) RR† (95% CI)
Age (years) 
  30–39 2.22 (1.30 to 3.81) 1.78 (1.03 to 3.07) 0.78 (0.37 to 1.63) 0.76 (0.37 to 1.58)
  40–49 1.79 (1.30 to 2.47) 1.58 (1.14 to 2.18) 1.07 (0.77 to 1.51) 1.11 (0.80 to 1.54)
  50–59 1.39 (1.06 to 1.82) 1.24 (0.94 to 1.64) 0.94 (0.71 to 1.24) 0.87 (0.66 to 1.15)
  60–69 0.99 (0.73 to 1.35) 1.02 (0.72 to 1.44) 1.25 (0.90 to 1.74) 1.34 (0.97 to 1.85)
P values, interaction categorical 
age and LBP
0.019 0.11 0.50 0.23
P values, interaction linear age 
and LBP
0.002 0.015 0.33 0.31
*Adjustment for baseline BMI, physical activity and smoking.
†RR for LBP versus no LBP.
BMI, body mass index; LBP, low back pain.
Table 5 Comorbidity between low back pain and diabetes 
at follow-up in the cohort study of individuals with neither 
low back pain nor diabetes at baseline*
Women Men
Adjustment for age






  P values 0.45 0.42
  Number of individuals included 10 131 8561
Complete adjustment†






  P values 0.24 0.90
  Number of individuals included 9488 8181
*Expressed by relative risk of diabetes comparing individuals with and 
without LBP at follow-up.
†Adjustment for baseline age, BMI, physical activity and smoking.
BMI, body mass index; LBP, low back pain.
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of low back pain was significantly higher among the 
patients with diabetes. A cross-sectional study using 
National Health and Nutrition Examination Survey data 
from the US adult population found higher prevalence of 
chronic low back pain among participants with diabetes.15 
In a study of Spanish twins,4 chronic back pain was found 
to be associated with the prevalence of type 2 diabetes in 
the cross-sectional analyses, with more consistent associa-
tions among women. These results are not in agreement 
with our cross-sectional results. In the analyses of a 2–4 
year follow-up of the Spanish twins,4 low back pain was 
not found to increase the risk of diabetes significantly, 
but in women the risk estimate was elevated, suggesting 
a stronger association than in our study. To our knowl-
edge, this is the only other longitudinal study reporting 
on associations between back pain and diabetes risk.
Studies based on other designs found mixed results 
regarding a potential association between diabetes and 
back pain. In a Swedish study based on a 4-year follow-up 
of a large population sample, an increased risk of frequent 
pain in the back, neck and/or shoulder was observed 
among men with diabetes without hyperlipidemia, but 
not among women.16 Among orthopedic patients with 
lumbar spinal stenosis, a higher prevalence of diabetes 
mellitus was found, compared with patients in the same 
clinic with a diagnosis of degenerative disc disease or with 
osteoporotic vertebral fractures.7 In a population study of 
twins in the UK, an association between type 2 diabetes 
and lumbar intervertebral disc degeneration disappeared 
after adjustment for BMI.5 In a patient material, markers 
of diabetes progression were associated with the presence 
of back pain.28 A Finnish cross-sectional study showed an 
association between chronic widespread pain including 
back pain and both diabetes and prediabetes.29
An earlier review of comorbidity between low back pain 
and other disorders included two cross-sectional studies 
reporting on diabetes.30 In one study, no comorbidity was 
found after adjustment, and in the other one, a nega-
tive association was observed. No comorbidity was found 
between low back pain and diabetes after adjustment in a 
German national survey.31
In animal models, changes in the vertebral endplates 
and discs were found in type 2 diabetic rats.32 In a mouse 
model, spinal degenerative changes in the vertebral 
structure were induced in a prediabetic state.33
A positive association between low back pain and risk 
of diabetes, as found in our study in women, could be 
ascribed to common underlying risk factors. However, 
taking into account the adjustment carried out here for 
BMI, physical activity and smoking, this seems unlikely. 
Otherwise, it is conceivable that low back pain directly 
affects factors that are important for later development 
of diabetes. Thus, low back pain may lead to less phys-
ical activity and consequently greater BMI, and in this 
way also an increased risk of diabetes. It is also possible 
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underlying physiological changes that may subsequently 
predispose to diabetes.
Inflammation may thus be part of the pathogenesis 
of both diabetes34 and low back pain.35 Inflammatory 
pathways are involved in the pathogenesis of insulin 
resistance, which is associated with a state of low-grade 
chronic inflammation in type 2 diabetes.36 Inflammatory 
mediators are also involved in insulin signaling path-
ways.37 Obesity is characterized by a proinflammatory 
condition with hypertrophied adipose tissue contributing 
to the level of proinflammatory cytokines.38 Pain gener-
ated by inflammatory changes mediated by substances 
released from fat cells may also provide a possible link 
to increased back pain. Thus, obesity may lead to low 
back pain through systemic chronic inflammation.9 39 An 
inflammatory process has in particular been associated 
with Modic type 1 vertebral endplate changes seen on 
MRI in some low back pain patients.40
Dyslipidaemia with reduced HDL and elevated 
triglyceride levels are associated with insulin resistance 
and type 2 diabetes.41 In previous analyses among the 
HUNT population, the prevalence of low back pain was 
found to be inversely associated with HDL cholesterol 
and positively associated with triglycerides, with stronger 
associations in women than in men.42 43 This is consistent 
with the suggestion that low back pain may be related 
to lumbar artery disease, with atherosclerosis in the 
feeding arteries producing reduced blood supply and 
disc degeneration.44
Levels of sex hormones may affect the development of 
diabetes24 and thus be responsible for the contrast in asso-
ciations with low back pain suggested in our study between 
women and men. Estrogens may have both anti-inflam-
matory and proinflammatory roles.45 Sex differences in 
diabetes risk have also been linked to differences in body 
weight,46 but this should be less important in our study 
since we have adjusted for BMI. Psychosocial factors may 
impact development of diabetes in a sex-specific manner,24 
and general sex differences in pain perception47 may affect 
the classification of back pain. A difference in risk estimates 
between women and men was also found in the longitu-
dinal analysis of low back pain as a risk factor for type 2 
diabetes in the Spanish twin study.4
In this study, the association between low back pain 
and diabetes was stronger in younger women. For 
type 2 diabetes, the disease onset and progression may 
be different in young people.48 In the cross-sectional 
HUNT2 study, type 1 diabetes (including latent autoim-
mune diabetes in adults) must be represented in all age 
groups, although most of the cases are likely of type 2 
diabetes.49 In contrast, our cohort study only comprises 
cases of diabetes diagnosed after the age of 30 years, and 
the vast majority will be cases of type 2 diabetes. Even 
in the youngest group of participants in our study, the 
majority of cases likely have type 2 diabetes, and type 
differences according to age can hardly explain the age 
differences in risk estimates found by us.
Although a positive association was found among 
women in our cohort study, no such association could 
be demonstrated in the cross-sectional data. Cross-sec-
tional results do not take into account temporal relation-
ships and may to a larger extent reflect a combination of 
different disease categories and underlying effects. This 
may also explain the heterogeneity in results considering 
other cross-sectional studies. It is more surprising in our 
study that no comorbidity was observed considering infor-
mation on diabetes and low back pain collected at the 
same time at the end of follow-up in the cohort data. The 
contrast with the positive association seen among women 
in the standard analysis of risk may be related to the differ-
ence in time lag. The dependence of the association in 
women on age at baseline may also be important, with 
reports of back pain in the comorbidity study being made 
about 11 years after those considered in the standard 
analyses.
CONCLUSION
Women without diabetes who suffer from chronic low 
back pain, have an increased risk of experiencing diabetes 
11 years later. The association is most pronounced among 
women younger than 40 years and diminishes with 
increasing age. In men, no association can be established. 
Among participants who do not suffer from diabetes or 
chronic low back pain, no comorbidity can be demon-
strated over an 11-year interval. These results should be 
confirmed in cohort studies in populations elsewhere.
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